4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-25-003768
Chief Patient Supply Officer sold 19,542 shares at an average $0.58 ($11,360)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lunger John Chief Patient Supply Officer | 2025-01-13 | Sale | −4,268 | $0.59 | $2,509 | 5,845 | D |
| Lunger John Chief Patient Supply Officer | 2025-01-13 | Sale | −5,471 | $0.59 | $3,216 | 7,623 | D |
| Lunger John Chief Patient Supply Officer | 2025-01-15 | Sale | −9,803 | $0.57 | $5,635 | 13,756 | D |
| Open-market sales · 19,542 sh · avg $0.58 · $11,360 | |||||||
Loading xslF345X05/tm253441-2_4seq1.xml…